Chester County News and Community Website
WAYNE, PA — Aclaris Therapeutics, Inc. (Nasdaq: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, this week announced the pricing of its underwritten public …
Aclaris Announces Pricing of Public Offering of Common Stock Read More WAYNE, PA — Aclaris Therapeutics, Inc. (Nasdaq: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, this week announced that it intends to offer and …
Aclaris Announces Proposed Public Offering of Common Stock Read More
EXTON, PA — Recro Pharma, Inc. (NASDAQ: REPH) on Friday announced the closing of its previously announced underwritten public offering of 15,333,332 shares of its common stock, including 1,999,999 shares …
Recro Raises $34.5 Million from Public Offering Read More
MALVERN, PA — PQ Group Holdings Inc. (NYSE: PQG) yesterday announced the pricing of the previously announced underwritten public offering by certain of its stockholders of 12,500,000 shares of its …
PQ Group Holdings Announces Pricing of Secondary Offering Read More
MALVERN, PA — Ocugen, Inc. (Nasdaq: OCGN) yesterday announced that it closed the previously announced registered direct offering with healthcare-focused institutional investors for the sale of an aggregate of 10 …
Ocugen Announces Closing of $100 Million Registered Direct Offering of Common Stock Read More MALVERN, PA — PQ Group Holdings Inc. (NYSE: PQG) this week announced that certain of its stockholders intend to offer for sale 12,500,000 shares of its common stock pursuant to …
PQ Group Holdings Announces Secondary Offering of 12,500,000 Shares Read More
MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, announced that it has entered into a definitive agreement with institutional and …
Baudax Bio Announces $17.6 Million Offering Read More MALVERN, PA — Ocugen, Inc. (Nasdaq: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, announced …
Ocugen Inc. Announces $23 Million Registered Direct Offering of Common Stock Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from …
Neuronetics Announces Closing of Public Offering Read More